Generate a tailored SOP for Dr. Sarah Turpin Nolan. Improve your application with a focused, well-structured draft.
Dr. Sarah Turpin-Nolan is currently a Research Fellow in the Cellular Molecular Metabolism laboratory at the Monash Institute of Pharmaceutical Sciences (MIPS), Monash University. Her research investigates the role of ceramides in metabolic diseases, particularly concerning the gastrointestinal tract and lymphatic transport systems. Previously, she contributed to the discovery of how specific ceramide species can help prevent diet-induced obesity and type 2 diabetes during her postdoctoral training in Prof. Jens Bruening's Laboratory at the Max Planck Institute for Metabolism Research, which led to the development of potential inhibitors for treating type 2 diabetes. Dr. Turpin-Nolan earned her PhD in Biology from the University of Melbourne, where she studied the metabolic consequences of lipid oversupply in key glucoregulatory tissues. Additionally, she holds a Bachelor of Applied Science (Biotechnology & Biomedical Science) with Honours from RMIT University, where she researched apoptosis in skeletal muscle myotubes related to insulin resistance. Her work aligns with the UN Sustainable Development Goals, contributing to global efforts to combat obesity and enhance metabolic health.
Monash Institute of Pharmaceutical Sciences • Melbourne, VIC
Conducting research on ceramides in metabolic diseases.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.